Bar graph icon

Proven to change hemoglobin (Hgb) levels

In a clinical trial, JESDUVROQ was as effective as an ESA, a current injectable treatment, in raising and maintaining Hgb levels during the evaluation period of Weeks 28 to 52. Your results may vary.

FIND OUT MORE >

Clipboard icon

Cardiovascular safety was clinically assessed

JESDUVROQ was compared to an ESA for incidence of serious cardiovascular events.

KNOW THE SAFETY INFORMATION >

Light bulb icon

JESDUVROQ works differently

JESDUVROQ is a novel treatment in a different class of medicine.

SHOW ME >

Homepage hero image 4

Being on dialysis and having Anemia of CKD can be a lot to manage. You may have questions or need a little extra support.

Check out our resources page, where you'll find an overview of advocacy groups to connect with other patients as well as answers to common questions about JESDUVROQ.